Doctor profile · Federal record
Dr. LARINDA OGAWA, PA-C
Medical Physician Assistant (CMS: PHYSICIAN ASSISTANT) · UNIVERSITY PLACE, WA
- NPI 1669740924
- Accepts Medicare
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5225 CIRQUE DR W STE 200
UNIVERSITY PLACE, WA 984673639
(253) 848-3000
fax (253) 845-8750 - Additional location
-
1703 S Meridian Ste 101
Puyallup, WA 983717590 - Mailing address
-
1703 S MERIDIAN STE 101
PUYALLUP, WA 983717590
Credentials & registration
- NPI registered
- December 2011 — 15 yrs on file
- Profile last updated
- April 6, 2018
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- Washington #60583901
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669740924. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,642
Distinct HCPCS
10
Medicare allowed
$128,285
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,171 | 186 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 352 | 289 | $76 | |
17000 |
Destruction of precancer skin growth, 1 growth | 285 | 230 | $46 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 175 | 142 | $107 | |
17110 |
Destruction of skin growth, 1-14 growths | 152 | 130 | $98 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 115 | 107 | $48 | |
11102 |
Biopsy of related skin growth, first growth | 97 | 92 | $79 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 60 | 60 | $95 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 42 | 35 | $146 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | 14 | $1 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 155. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$658
Transactions
34
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 18 | $220.73 | |
| Janssen Biotech, Inc. | 3 | $108.13 | |
| Amgen Inc. | 3 | $94.32 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $68.71 | |
| UCB, Inc. | 2 | $50.09 | |
| Novartis Pharmaceuticals Corporation | 2 | $44.73 | |
| PFIZER INC. | 2 | $38.11 | |
| Lilly USA, LLC | 1 | $16.88 | |
| MERZ NORTH AMERICA, INC. | 1 | $16.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
343
Patients
221
Total drug cost
$105,106
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 70 | 59 | $883 |
| Hydrocortisone | Generic | 54 | 45 | $353 |
| Clobetasol Propionate | Generic | 53 | 35 | $3,880 |
| Ketoconazole | Generic | 48 | 29 | $808 |
| Betamethasone Dipropionate | Generic | 41 | 20 | $3,986 |
| Fluorouracil | Generic | 23 | 22 | $2,671 |
| Metronidazole | Generic | 16 | 11 | $855 |
| Clindamycin Phosphate | Generic | 15 | 0 | $827 |
| Humira(Cf) Pen (Adalimumab) | Brand | 12 | 0 | $90,588 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 11 | 0 | $256 |